Castle Biosciences (CSTL) Beats Q2 Earnings Estimates by $0.34
Earnings Results Castle Biosciences (NASDAQ:CSTL) reported quarterly earnings results on July 30, 2026 that exceeded analyst expectations. The Healthcare company reported earnings…
Read more
